Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compositions and methods for immunotherapy

Compositions and methods for immunotherapy

US Patent 11712477 · Granted Aug 1, 2023

Estimated economic value: $225,000 ⓘ

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibody specific for CD22 and methods of use thereof2024
Engineered chimeric fusion protein compositions and methods of use thereof2024
Anti-kit antibodies and uses thereof2024
Anti-kit antibodies and uses thereof2024
Anti-MET antibodies and methods of use thereof2024
Anti-MET antibodies and methods of use thereof2024
Humanized antibodies against CEACAM12024
Humanized antibodies against CEACAM12024
Polypeptides comprising a modified bacteriophage G3P amino acid sequence lacking2023
Polypeptides comprising a modified bacteriophage G3P amino acid sequence lacking2023
Engineered chimeric fusion protein compositions and methods of use thereof2023
Nanoparticle compositions and methods for immunotherapy2022